Detalles de la búsqueda
1.
Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.
Proc Natl Acad Sci U S A
; 106(10): 3889-94, 2009 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19234124
2.
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers.
J Exp Med
; 202(3): 379-86, 2005 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16061727
3.
CD8(+) T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect.
Haematologica
; 95(9): 1572-8, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20460638
4.
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
Am J Hematol
; 85(4): 261-3, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20201088
5.
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.
J Clin Oncol
; 23(36): 9387-93, 2005 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16314618
6.
Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.
Lancet
; 365(9475): 1934-41, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15936420
7.
Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease.
Transplantation
; 75(2): 221-5, 2003 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-12548127
8.
CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation.
Blood
; 110(12): 3827-32, 2007 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17766680
9.
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
Br J Haematol
; 139(1): 70-80, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17854309
10.
Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation.
Blood
; 107(3): 1230-2, 2006 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16239436
11.
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study.
Br J Haematol
; 134(4): 385-90, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16822294
12.
Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells.
Blood
; 103(6): 2410-6, 2004 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14604970
13.
The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia.
Blood
; 103(4): 1521-6, 2004 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14504099
14.
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.
Blood
; 99(12): 4357-63, 2002 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12036862
15.
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen.
Blood
; 99(3): 1071-8, 2002 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11807015
Resultados
1 -
15
de 15
1
Próxima >
>>